miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1

INTRODUCTION: Prostate cancer (PCa) is one of the most common types of cancer in men. In the course of the development and progression of this disease, abnormal expression of miR-203 is usually accompanied. However, its role in prostate tumorigenesis and the underlying mechanism are poorly understoo...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Yang, Hu, Xiaoyan, Li, Shasha, Zeng, Xinyi, Qiu, Lei, Wei, Mingtian, Wang, Ziqing, Han, Junhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590475/
https://www.ncbi.nlm.nih.gov/pubmed/33109107
http://dx.doi.org/10.1186/s12885-020-07472-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590475/
https://www.ncbi.nlm.nih.gov/pubmed/33109107
http://dx.doi.org/10.1186/s12885-020-07472-2

Ejemplares similares